High linear energy transfer carbon-ion irradiation upregulates PD-L1 expression more significantly than X-rays in human osteosarcoma U2OS cells
Programmed death ligand 1 (PD-L1) expression on the surface of cancer cells affects the efficacy of anti-PD-1/PD-L1 immune checkpoint therapy. However, the mechanism underlying PD-L1 expression in cancer cells is not fully understood, particularly after ionizing radiation (IR). Here, we examined the...
Saved in:
Published in | Journal of radiation research Vol. 62; no. 5; pp. 773 - 781 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.09.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0449-3060 1349-9157 1349-9157 |
DOI | 10.1093/jrr/rrab050 |
Cover
Abstract | Programmed death ligand 1 (PD-L1) expression on the surface of cancer cells affects the efficacy of anti-PD-1/PD-L1 immune checkpoint therapy. However, the mechanism underlying PD-L1 expression in cancer cells is not fully understood, particularly after ionizing radiation (IR). Here, we examined the impact of high linear energy transfer (LET) carbon-ion irradiation on the expression of PD-L1 in human osteosarcoma U2OS cells. We found that the upregulation of PD-L1 expression after high LET carbon-ion irradiation was greater than that induced by X-rays at the same physical and relative biological effectiveness (RBE) dose, and that the upregulation of PD-L1 induced by high LET carbon-ion irradiation was predominantly dependent on ataxia telangiectasia and Rad3-related (ATR) kinase activity. Moreover, we showed that the downstream signaling, e.g. STAT1 phosphorylation and IRF1 expression, was upregulated to a greater extent after high LET carbon-ion irradiation than X-rays, and that IRF1 upregulation was also ATR dependent. Finally, to visualize PD-L1 molecules on the cell surface in 3D, we applied immunofluorescence-based super-resolution imaging. The three-dimensional structured illumination microscopy (3D-SIM) analyses revealed substantial increases in the number of presented PD-L1 molecules on the cell surface after high LET carbon-ion irradiation compared with X-ray irradiation. |
---|---|
AbstractList | Programmed death ligand 1 (PD-L1) expression on the surface of cancer cells affects the efficacy of anti-PD-1/PD-L1 immune checkpoint therapy. However, the mechanism underlying PD-L1 expression in cancer cells is not fully understood, particularly after ionizing radiation (IR). Here, we examined the impact of high linear energy transfer (LET) carbon-ion irradiation on the expression of PD-L1 in human osteosarcoma U2OS cells. We found that the upregulation of PD-L1 expression after high LET carbon-ion irradiation was greater than that induced by X-rays at the same physical and relative biological effectiveness (RBE) dose, and that the upregulation of PD-L1 induced by high LET carbon-ion irradiation was predominantly dependent on ataxia telangiectasia and Rad3-related (ATR) kinase activity. Moreover, we showed that the downstream signaling, e.g. STAT1 phosphorylation and IRF1 expression, was upregulated to a greater extent after high LET carbon-ion irradiation than X-rays, and that IRF1 upregulation was also ATR dependent. Finally, to visualize PD-L1 molecules on the cell surface in 3D, we applied immunofluorescence-based super-resolution imaging. The three-dimensional structured illumination microscopy (3D-SIM) analyses revealed substantial increases in the number of presented PD-L1 molecules on the cell surface after high LET carbon-ion irradiation compared with X-ray irradiation. Programmed death ligand 1 (PD-L1) expression on the surface of cancer cells affects the efficacy of anti-PD-1/PD-L1 immune checkpoint therapy. However, the mechanism underlying PD-L1 expression in cancer cells is not fully understood, particularly after ionizing radiation (IR). Here, we examined the impact of high linear energy transfer (LET) carbon-ion irradiation on the expression of PD-L1 in human osteosarcoma U2OS cells. We found that the upregulation of PD-L1 expression after high LET carbon-ion irradiation was greater than that induced by X-rays at the same physical and relative biological effectiveness (RBE) dose, and that the upregulation of PD-L1 induced by high LET carbon-ion irradiation was predominantly dependent on ataxia telangiectasia and Rad3-related (ATR) kinase activity. Moreover, we showed that the downstream signaling, e.g. STAT1 phosphorylation and IRF1 expression, was upregulated to a greater extent after high LET carbon-ion irradiation than X-rays, and that IRF1 upregulation was also ATR dependent. Finally, to visualize PD-L1 molecules on the cell surface in 3D, we applied immunofluorescence-based super-resolution imaging. The three-dimensional structured illumination microscopy (3D-SIM) analyses revealed substantial increases in the number of presented PD-L1 molecules on the cell surface after high LET carbon-ion irradiation compared with X-ray irradiation.Programmed death ligand 1 (PD-L1) expression on the surface of cancer cells affects the efficacy of anti-PD-1/PD-L1 immune checkpoint therapy. However, the mechanism underlying PD-L1 expression in cancer cells is not fully understood, particularly after ionizing radiation (IR). Here, we examined the impact of high linear energy transfer (LET) carbon-ion irradiation on the expression of PD-L1 in human osteosarcoma U2OS cells. We found that the upregulation of PD-L1 expression after high LET carbon-ion irradiation was greater than that induced by X-rays at the same physical and relative biological effectiveness (RBE) dose, and that the upregulation of PD-L1 induced by high LET carbon-ion irradiation was predominantly dependent on ataxia telangiectasia and Rad3-related (ATR) kinase activity. Moreover, we showed that the downstream signaling, e.g. STAT1 phosphorylation and IRF1 expression, was upregulated to a greater extent after high LET carbon-ion irradiation than X-rays, and that IRF1 upregulation was also ATR dependent. Finally, to visualize PD-L1 molecules on the cell surface in 3D, we applied immunofluorescence-based super-resolution imaging. The three-dimensional structured illumination microscopy (3D-SIM) analyses revealed substantial increases in the number of presented PD-L1 molecules on the cell surface after high LET carbon-ion irradiation compared with X-ray irradiation. |
Author | Shibata, Atsushi Gondhowiardjo, Soehartati Tsushima, Yoshito Gu, Wenchao Ohno, Tatsuya Permata, Tiara Bunga Mayang Sato, Hiro Suzuki, Keiji Kato, Reona Yasuhara, Takaaki Uchihara, Yuki Yamauchi, Motohiro Sato, Itaru Oike, Takahiro Kakoti, Sangeeta Yoshimatsu, Yukihiko |
Author_xml | – sequence: 1 givenname: Tiara Bunga Mayang surname: Permata fullname: Permata, Tiara Bunga Mayang – sequence: 2 givenname: Hiro surname: Sato fullname: Sato, Hiro – sequence: 3 givenname: Wenchao surname: Gu fullname: Gu, Wenchao email: shibata.at@gunma-u.ac.jp – sequence: 4 givenname: Sangeeta surname: Kakoti fullname: Kakoti, Sangeeta – sequence: 5 givenname: Yuki surname: Uchihara fullname: Uchihara, Yuki – sequence: 6 givenname: Yukihiko surname: Yoshimatsu fullname: Yoshimatsu, Yukihiko – sequence: 7 givenname: Itaru surname: Sato fullname: Sato, Itaru – sequence: 8 givenname: Reona surname: Kato fullname: Kato, Reona – sequence: 9 givenname: Motohiro surname: Yamauchi fullname: Yamauchi, Motohiro – sequence: 10 givenname: Keiji surname: Suzuki fullname: Suzuki, Keiji – sequence: 11 givenname: Takahiro surname: Oike fullname: Oike, Takahiro – sequence: 12 givenname: Yoshito surname: Tsushima fullname: Tsushima, Yoshito – sequence: 13 givenname: Soehartati surname: Gondhowiardjo fullname: Gondhowiardjo, Soehartati – sequence: 14 givenname: Tatsuya surname: Ohno fullname: Ohno, Tatsuya – sequence: 15 givenname: Takaaki surname: Yasuhara fullname: Yasuhara, Takaaki – sequence: 16 givenname: Atsushi surname: Shibata fullname: Shibata, Atsushi email: shibata.at@gunma-u.ac.jp |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34196706$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kt-L1DAQx4OceHunT75LQBBB6iVN0zQvgpw_Tlg4QQ98C9N0upulTdakFfev8F826-6JHuJTJpnPfPMdZs7IiQ8eCXnM2UvOtLjYxHgRI7RMsntkwUWlC82lOiELVuVYsJqdkrOUNoyVKkMPyKmouK4Vqxfkx5VbrengPEKk6DGudnSK4FOPkVqIbfCFC566_EPnYNrH8zbiah5gwkQ_vimWnOL3_JTSPjmGiDS5lXe9s-CnIeutwdMvRYRdos7T9Tzme0gThgTRhhHoTXn9iVochvSQ3O9hSPjoeJ6Tm3dvP19eFcvr9x8uXy8LKwWbik6WNQcGumkrXWnBsVE1aK5Ri5LXosUeK16hkNKyFiRTfYe8U4x1NajGinPy6qC7ndsRO4s-dz2YbXQjxJ0J4MzfGe_WZhW-maYSTSmbLPD8KBDD1xnTZEaX9i2AxzAnU8pKSaFFLTL69A66CXP0uT0juOJc6aYqM_XkT0e_rdzOKgP8ANgYUorYG-umXxPJBt1gODP7fTB5H8xxH3LNizs1t7L_pp8d6DBv_wv-BEvhyDY |
CitedBy_id | crossref_primary_10_1016_j_ecoenv_2025_117689 crossref_primary_10_31083_j_fbl2709277 crossref_primary_10_3390_cancers13194893 crossref_primary_10_1007_s11307_023_01857_y crossref_primary_10_3389_fonc_2024_1371752 crossref_primary_10_3892_ol_2021_13147 crossref_primary_10_1016_j_canlet_2023_216268 crossref_primary_10_1002_cam4_6742 crossref_primary_10_3389_fpls_2023_1056662 crossref_primary_10_1016_j_canlet_2022_215887 crossref_primary_10_1186_s13046_022_02469_0 crossref_primary_10_1016_j_dnarep_2024_103626 crossref_primary_10_1016_j_dnarep_2023_103590 crossref_primary_10_1016_j_jare_2024_12_023 crossref_primary_10_3389_fphar_2022_1031527 crossref_primary_10_1002_cnr2_1825 crossref_primary_10_3389_fcell_2024_1422520 crossref_primary_10_1093_jrr_rrad107 crossref_primary_10_15212_AMM_2022_0024 crossref_primary_10_32604_phyton_2023_042919 crossref_primary_10_3390_cells13121058 crossref_primary_10_1038_s41416_022_02117_6 |
Cites_doi | 10.1016/j.mrfmmm.2017.07.011 10.3389/fonc.2019.00156 10.1038/nature14292 10.3389/fonc.2016.00139 10.1038/s41586-018-0629-6 10.1259/bjr.20130626 10.1186/s40425-018-0361-7 10.1158/2159-8290.CD-18-1020 10.1016/j.clon.2014.02.004 10.1186/s12929-017-0329-9 10.1038/s41388-019-0733-6 10.1016/j.celrep.2017.04.031 10.18632/oncotarget.22679 10.1038/nature23470 10.1016/S1470-2045(16)30498-3 10.1172/JCI123319 10.1016/j.dnarep.2013.08.009 10.18632/oncotarget.26551 10.1016/S1470-2045(15)00007-8 10.1016/j.celrep.2020.108080 10.1016/S1470-2045(14)70412-7 10.1128/JVI.00006-17 10.1038/nrclinonc.2013.79 10.1038/nrclinonc.2017.30 10.1016/j.canlet.2017.08.006 10.1038/s41467-017-01883-9 10.1038/nrc.2016.36 10.1038/emboj.2011.27 10.1016/j.molcel.2009.03.004 10.1038/nature23449 10.3802/jgo.2020.31.e19 10.1038/nature21349 |
ContentType | Journal Article |
Copyright | The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. 2021 The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. 2021 – notice: The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. – notice: The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | TOX AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8AO 8FE 8FG 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH HCIFZ K9. M0S P5Z P62 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1093/jrr/rrab050 |
DatabaseName | Oxford Journals Open Access Collection CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Central Technology collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Collection ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) Advanced Technologies & Aerospace Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1349-9157 |
EndPage | 781 |
ExternalDocumentID | PMC8438258 34196706 10_1093_jrr_rrab050 10.1093/jrr/rrab050 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Japan Society for the Promotion of Science grantid: JP19K08195 – fundername: ; grantid: JP19K08195; JP17H04713 |
GroupedDBID | --- -~X .I3 0R~ 29L 2WC 4.4 53G 5GY 5VS 7.U 8WZ A6W AAFWJ AAMVS AAOGV AAPPN AAPXW AAVAP AAWTL ABAZT ABEFU ABEJV ABGNP ABPTD ABQLI ABWST ABXVV ACFRR ACGFS ACUTJ ADBBV ADHZD ADMLS ADRAZ AENEX AENZO AFFNX AFPKN AFULF AGQXC ALMA_UNASSIGNED_HOLDINGS ALUQC AMNDL AOIJS BAWUL BAYMD BCNDV BEFXN BFFAM BGNUA BKEBE BKOMP BPEOZ BTTYL CIDKT CS3 DIK DU5 D~K E3Z EBS EJD EMOBN F5P GROUPED_DOAJ GX1 H13 HH5 HYE IAO IHR INH ITC JAVBF JMI JSF JSH KSI M48 ML0 MOJWN M~E O9- OAWHX OCL OJQWA OK1 O~Y P2P PEELM RHF RJT RNS ROL ROX RPM RXO RYR RZJ TKC TOX TR2 UDS W2D XSB ~D7 7X7 8AO 8FI 8FJ AAYXX ABUWG ABVLG AFKRA ARAPS BENPR BGLVJ CCPQU CITATION FYUFA HCIFZ HMCUK OVT PHGZM PHGZT PIMPY UKHRP CGR CUY CVF ECM EIF NPM 3V. 7XB 8FE 8FG 8FK AZQEC DWQXO K9. P62 PKEHL PQEST PQGLB PQQKQ PQUKI PRINS PUEGO 7X8 5PM |
ID | FETCH-LOGICAL-c530t-d5261a0a98b494931e876a919e932163befe414e355c0ba507fde1d700d6a78c3 |
IEDL.DBID | M48 |
ISSN | 0449-3060 1349-9157 |
IngestDate | Thu Aug 21 14:09:20 EDT 2025 Fri Sep 05 00:52:44 EDT 2025 Sat Aug 23 14:30:16 EDT 2025 Wed Feb 19 02:27:26 EST 2025 Thu Apr 24 23:05:09 EDT 2025 Tue Jul 01 00:41:46 EDT 2025 Fri Feb 07 10:35:36 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | high linear energy transfer (LET) carbon-ion therapy PD-L1 expression DNA damage response anti-PD-1/PD-L1 therapy |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c530t-d5261a0a98b494931e876a919e932163befe414e355c0ba507fde1d700d6a78c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Tiara Bunga Mayang Permata, Hiro Sato, Wenchao Gu, Sangeeta Kakoti contributed equally to this work. |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1093/jrr/rrab050 |
PMID | 34196706 |
PQID | 3171179842 |
PQPubID | 1976363 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8438258 proquest_miscellaneous_2547539363 proquest_journals_3171179842 pubmed_primary_34196706 crossref_citationtrail_10_1093_jrr_rrab050 crossref_primary_10_1093_jrr_rrab050 oup_primary_10_1093_jrr_rrab050 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-09-01 |
PublicationDateYYYYMMDD | 2021-09-01 |
PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Journal of radiation research |
PublicationTitleAlternate | J Radiat Res |
PublicationYear | 2021 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Feng (2021091406020809000_ref7) 2017; 407 Rhind (2021091406020809000_ref25) 2009; 33 Sen (2021091406020809000_ref26) 2019; 9 Chen (2021091406020809000_ref31) 2020; 32 Sato (2021091406020809000_ref15) 2017; 8 Takahashi (2021091406020809000_ref13) 2019; 10 Deschamps (2021091406020809000_ref18) 2017; 91 Harding (2021091406020809000_ref28) 2017; 548 Shibata (2021091406020809000_ref23) 2014; 26 Garcia-Diaz (2021091406020809000_ref21) 2017; 19 Chabanon (2021091406020809000_ref27) 2019; 129 Iijima (2021091406020809000_ref14) 2020; 31 Liu (2021091406020809000_ref30) 2018; 563 Oike (2021091406020809000_ref22) 2016; 6 Shibata (2021091406020809000_ref24) 2017; 803-805 Shibata (2021091406020809000_ref20) 2011; 30 Permata (2021091406020809000_ref16) 2019; 38 Mackenzie (2021091406020809000_ref29) 2017; 548 Sharabi (2021091406020809000_ref11) 2015; 16 Durante (2021091406020809000_ref2) 2014; 87 Hagiwara (2021091406020809000_ref17) 2017; 8 Twyman-Saint Victor (2021091406020809000_ref9) 2015; 520 Topalian (2021091406020809000_ref6) 2016; 16 Yajima (2021091406020809000_ref19) 2013; 12 Loeffler (2021091406020809000_ref1) 2013; 10 Kamada (2021091406020809000_ref32) 2015; 16 Langer (2021091406020809000_ref10) 2016; 17 Shevtsov (2021091406020809000_ref8) 2019; 9 Gong (2021091406020809000_ref12) 2018; 6 Durante (2021091406020809000_ref3) 2017; 14 Iwai (2021091406020809000_ref4) 2017; 24 Chen (2021091406020809000_ref5) 2017; 541 |
References_xml | – volume: 803-805 start-page: 51 year: 2017 ident: 2021091406020809000_ref24 article-title: Regulation of repair pathway choice at two-ended DNA double-strand breaks publication-title: Mutat Res doi: 10.1016/j.mrfmmm.2017.07.011 – volume: 9 start-page: 156 year: 2019 ident: 2021091406020809000_ref8 article-title: Novel approaches to improve the Eeficacy of immuno-radiotherapy publication-title: Front Oncol doi: 10.3389/fonc.2019.00156 – volume: 520 start-page: 373 year: 2015 ident: 2021091406020809000_ref9 article-title: Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer publication-title: Nature doi: 10.1038/nature14292 – volume: 6 start-page: 139 year: 2016 ident: 2021091406020809000_ref22 article-title: Translational research to improve the efficacy of carbon ion radiotherapy: experience of Gunma University publication-title: Front Oncol doi: 10.3389/fonc.2016.00139 – volume: 563 start-page: 131 year: 2018 ident: 2021091406020809000_ref30 article-title: Nuclear cGAS suppresses DNA repair and promotes tumorigenesis publication-title: Nature doi: 10.1038/s41586-018-0629-6 – volume: 87 start-page: 20130626 year: 2014 ident: 2021091406020809000_ref2 article-title: New challenges in high-energy particle radiobiology publication-title: Br J Radiol doi: 10.1259/bjr.20130626 – volume: 6 start-page: 46 year: 2018 ident: 2021091406020809000_ref12 article-title: Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination publication-title: J Immunother Cancer doi: 10.1186/s40425-018-0361-7 – volume: 9 start-page: 646 year: 2019 ident: 2021091406020809000_ref26 article-title: Targeting DNA damage response promotes antitumor immunity through STING-mediated t-cell activation in small cell lung cancer publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-18-1020 – volume: 26 start-page: 243 year: 2014 ident: 2021091406020809000_ref23 article-title: DNA double-strand break repair in a cellular context publication-title: Clin Oncol doi: 10.1016/j.clon.2014.02.004 – volume: 24 start-page: 26 year: 2017 ident: 2021091406020809000_ref4 article-title: Cancer immunotherapies targeting the PD-1 signaling pathway publication-title: J Biomed Sci doi: 10.1186/s12929-017-0329-9 – volume: 38 start-page: 4452 year: 2019 ident: 2021091406020809000_ref16 article-title: Base excision repair regulates PD-L1 expression in cancer cells publication-title: Oncogene doi: 10.1038/s41388-019-0733-6 – volume: 19 start-page: 1189 year: 2017 ident: 2021091406020809000_ref21 article-title: Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression publication-title: Cell Rep doi: 10.1016/j.celrep.2017.04.031 – volume: 8 start-page: 109370 year: 2017 ident: 2021091406020809000_ref17 article-title: 3D-structured illumination microscopy reveals clustered DNA double-strand break formation in widespread gammaH2AX foci after high LET heavy-ion particle radiation publication-title: Oncotarget doi: 10.18632/oncotarget.22679 – volume: 548 start-page: 466 year: 2017 ident: 2021091406020809000_ref28 article-title: Mitotic progression following DNA damage enables pattern recognition within micronuclei publication-title: Nature doi: 10.1038/nature23470 – volume: 17 start-page: 1497 year: 2016 ident: 2021091406020809000_ref10 article-title: Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)30498-3 – volume: 129 start-page: 1211 year: 2019 ident: 2021091406020809000_ref27 article-title: PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer publication-title: J Clin Invest doi: 10.1172/JCI123319 – volume: 12 start-page: 936 year: 2013 ident: 2021091406020809000_ref19 article-title: The complexity of DNA double strand breaks is a critical factor enhancing end-resection publication-title: DNA Repair doi: 10.1016/j.dnarep.2013.08.009 – volume: 10 start-page: 633 year: 2019 ident: 2021091406020809000_ref13 article-title: Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma publication-title: Oncotarget doi: 10.18632/oncotarget.26551 – volume: 16 start-page: e498 year: 2015 ident: 2021091406020809000_ref11 article-title: Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)00007-8 – volume: 32 start-page: 108080 year: 2020 ident: 2021091406020809000_ref31 article-title: Cell cycle checkpoints cooperate to suppress DNA- and RNA-associated molecular pattern recognition and anti-tumor immune responses publication-title: Cell Rep doi: 10.1016/j.celrep.2020.108080 – volume: 16 start-page: e93 year: 2015 ident: 2021091406020809000_ref32 article-title: Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience publication-title: Lancet Oncol doi: 10.1016/S1470-2045(14)70412-7 – volume: 91 year: 2017 ident: 2021091406020809000_ref18 article-title: Impaired STING pathway in human osteosarcoma U2OS cells contributes to the growth of ICP0-null mutant herpes simplex virus publication-title: J Virol doi: 10.1128/JVI.00006-17 – volume: 10 start-page: 411 year: 2013 ident: 2021091406020809000_ref1 article-title: Charged particle therapy—optimization, challenges and future directions publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2013.79 – volume: 14 start-page: 483 year: 2017 ident: 2021091406020809000_ref3 article-title: Charged-particle therapy in cancer: clinical uses and future perspectives publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2017.30 – volume: 407 start-page: 57 year: 2017 ident: 2021091406020809000_ref7 article-title: PD-1/PD-L1 and immunotherapy for pancreatic cancer publication-title: Cancer Lett doi: 10.1016/j.canlet.2017.08.006 – volume: 8 start-page: 1751 year: 2017 ident: 2021091406020809000_ref15 article-title: DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells publication-title: Nat Commun doi: 10.1038/s41467-017-01883-9 – volume: 16 start-page: 275 year: 2016 ident: 2021091406020809000_ref6 article-title: Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy publication-title: Nat Rev Cancer doi: 10.1038/nrc.2016.36 – volume: 30 start-page: 1079 year: 2011 ident: 2021091406020809000_ref20 article-title: Factors determining DNA double-strand break repair pathway choice in G2 phase publication-title: EMBO J doi: 10.1038/emboj.2011.27 – volume: 33 start-page: 672 year: 2009 ident: 2021091406020809000_ref25 article-title: Changing of the guard: how ATM hands off DNA double-strand break signaling to ATR publication-title: Mol Cell doi: 10.1016/j.molcel.2009.03.004 – volume: 548 start-page: 461 year: 2017 ident: 2021091406020809000_ref29 article-title: cGAS surveillance of micronuclei links genome instability to innate immunity publication-title: Nature doi: 10.1038/nature23449 – volume: 31 start-page: e19 year: 2020 ident: 2021091406020809000_ref14 article-title: Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma publication-title: J Gynecol Oncol doi: 10.3802/jgo.2020.31.e19 – volume: 541 start-page: 321 year: 2017 ident: 2021091406020809000_ref5 article-title: Elements of cancer immunity and the cancer-immune set point publication-title: Nature doi: 10.1038/nature21349 |
SSID | ssj0027050 |
Score | 2.4061363 |
Snippet | Programmed death ligand 1 (PD-L1) expression on the surface of cancer cells affects the efficacy of anti-PD-1/PD-L1 immune checkpoint therapy. However, the... |
SourceID | pubmedcentral proquest pubmed crossref oup |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 773 |
SubjectTerms | Ataxia Ataxia Telangiectasia Mutated Proteins - antagonists & inhibitors Ataxia Telangiectasia Mutated Proteins - physiology B7-H1 Antigen - biosynthesis B7-H1 Antigen - genetics Biological effects Bone cancer Bone Neoplasms - pathology Cancer Carbon Cell Line, Tumor Effectiveness Energy transfer Fundamental Radiation Science Gene Expression Regulation, Neoplastic - radiation effects Heavy Ion Radiotherapy Humans Image resolution Imaging, Three-Dimensional Immunofluorescence Interferon Regulatory Factor-1 - biosynthesis Interferon Regulatory Factor-1 - genetics Ion irradiation Ionizing radiation Kinases Linear Energy Transfer Linear energy transfer (LET) Morpholines - pharmacology Neoplasm Proteins - antagonists & inhibitors Neoplasm Proteins - biosynthesis Neoplasm Proteins - genetics Osteosarcoma - pathology Phosphorylation Phosphorylation - radiation effects Protein Processing, Post-Translational - radiation effects Pyrazines - pharmacology Pyrones - pharmacology Relative biological effectiveness (RBE) RNA, Messenger - biosynthesis RNA, Messenger - genetics RNA, Neoplasm - biosynthesis RNA, Neoplasm - genetics Sarcoma STAT1 Transcription Factor - metabolism Sulfones - pharmacology Up-Regulation - radiation effects X ray irradiation X-Rays |
SummonAdditionalLinks | – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgCMQLGuPHAgMOaU9IVp0fTeInhAZlQgyQoFLfIjt2tKLNKU4rsb-Cf5m7xO1ahPZsK7Hyne3vct_dMXZMVb0TUWgurUw5BYZ4KYXhFIVChiq1KClR-OxLfjrNPs3Gs_DDrQuyyvWZ2B_Upq3pH_kI7zmqXlZmydvFL05doyi6Glpo3GZ3YrxpyM7Lycdrh0v0HVpFllF8PxchPw-d-NFP70feKy0o4X7rRtrJctsim_9qJrcuock-exDYI7wb4H7Ibll3wO4O_SSvDti9sxApf8T-kIADiEMqD7ZP8INlT1Kth1p53TqOkMAcl2cGeGC18ENnetvBt_f8cwz2d9DJOiBBLpDag7RFCMcFPu9cOZhxr646mDvo2_0BJY20HW6f9lLBNPn6HSg20D1m08mHHyenPDRf4PU4FUtuxuhbKaFkqamATRpbPDeVjAnTBEmcto3N4swiX6mFVkgrG2NjUwhhclWUdfqE7bnW2UMGddaIpJZFqgySCdtIZRGRRiOkeL6YJGJv1gBUdahMTg0yLqohQp5WiFYV0IrY8WbyYijI8f9prxDJm2ccrVGuwr7tqmsri9jrzTDuOPpUytl21VXoUqOPJ9M8jdjTwSg276HqeHkh8ogVO-aymUDVvHdH3Py8r-pdUkh2XD67eVnP2f2EVDW9yu2I7S39yr5AWrTUL3vb_wtaIg8v priority: 102 providerName: ProQuest |
Title | High linear energy transfer carbon-ion irradiation upregulates PD-L1 expression more significantly than X-rays in human osteosarcoma U2OS cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34196706 https://www.proquest.com/docview/3171179842 https://www.proquest.com/docview/2547539363 https://pubmed.ncbi.nlm.nih.gov/PMC8438258 |
Volume | 62 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VVlS9oFJegTYsUk9IS9eP2N4DQi00VIi0FTSSb9auvVaDgl3WidT8Cv4yM36EpKo4cPHFa3vlb9b7jWfmG4BDUvV2Rai5NNLjFBjikRQZpygUMlSpRUSFwqPz4Gzsf4kH8QZ0zTjbF1jd69pRP6mxnb67_bX4gAv-fSuGdPTD2iNrlRbku2_hlhSQFzbyo7-el6hbtQrfp0B_INpCvTsX78A2qZsFIbU_Wtml1irfVgjo3TzKlY1puAuPWkbJjhsTeAwbptiDh02PycUebI_a6PkT-E1JHYx4pbLM1EV_bFYTV2NZqqwuC44wsQnONGsgY_Mb23SrNxW7_MS_OszctrmzBaMkXUYZIJRvhBBN8X7XqmAxt2pRsUnB6haAjApJygqXVPlTsbF78Z1RvKB6CuPh6dXHM942ZODpwBMzng3Q31JCyUiTqI3nGPyWKukQzi4SO21y4zu-QQ6TCq2QauaZcbJQiCxQYZR6z2CzKAvzAljq58JNZeipDAmGyaUyCE6ukc7gNydze_C2AyBJW7VyapoxTZqouZcgcEkLXA8Ol4NvGpGO-4e9RiT_PWK_QznpTDHBKZFuXuTjpN4sT-MqpFelClPOqwTdbPT7pBd4PXjeGMXyOZ1N9SBcM5flAFL4Xj9TTK5rpe-IwrSD6OV_X_kKdlxKwqmT4vZhc2bn5gBZ1Ez34UEYh3iMhp_7sHVyen75rV__kejXawePVxfxH1BLJR0 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB2VIi4vCMrNUOgilRekVdaX2N4HhBClSmlSkGikvLm79poGFTusE0G-gj_hG5nxJSQI9a3PXjmrnNnZM54zMwD71NXbE5Hm0kifU2KIx1JknLJQyFClFjEVCo9OwsE4-DDpT7bgd1cLQ7LKzifWjjorU_pG3sN7jrqXxYH3Zvad09Qoyq52IzQaszg2yx8YslWvjw4Q35eed_j-9N2At1MFeNr3xZxnfQwalFAy1tSZxXcNOgQlXdqsh-xEm9wEbmDwIk6FVsiX8sy4WSREFqooTn187zW4HtCXcTw_0WQtwBP1RFgRBKQnCEVbDyik3_tqbc9apQUV-K_dgBtVdWvk9l-N5tqld3gX7rRslb1tzOsebJliB2408yuXO3Bz1Gbm78MvEoww4qzKMlMXFLJ5TYqNZamyuiw4mgCb4vayxhzYYmbNFxofZir26YAPXWZ-trrcgpEAmJG6hLRMCP8Fvu9cFWzCrVpWbFqwerwgoyKVskJcym-Kjb2PnxnlIqoHML4SWB7CdlEW5jGwNMiFl8rIVxmSF5NLZRCRXKMJoT_LPAdedQAkadsJnQZyXCRNRt5PEK2kRcuB_dXiWdMA5P_L9hDJy1fsdignrZ-okr9W7cCL1WM84fRXqcKUiyrBEB5jSumHvgOPGqNY_Q514wsjEToQbZjLagF1D998UkzP6y7iMaWA-_GTy7e1B7cGp6NhMjw6OX4Ktz1S9NQKu13YntuFeYaUbK6f1-eAwdlVH7w_tydLDA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+linear+energy+transfer+carbon-ion+irradiation+upregulates+PD-L1+expression+more+significantly+than+X-rays+in+human+osteosarcoma+U2OS+cells&rft.jtitle=Journal+of+radiation+research&rft.au=Permata%2C+Tiara+Bunga+Mayang&rft.au=Sato%2C+Hiro&rft.au=Gu%2C+Wenchao&rft.au=Kakoti%2C+Sangeeta&rft.date=2021-09-01&rft.pub=Oxford+University+Press&rft.issn=0449-3060&rft.eissn=1349-9157&rft.volume=62&rft.issue=5&rft.spage=773&rft.epage=781&rft_id=info:doi/10.1093%2Fjrr%2Frrab050&rft_id=info%3Apmid%2F34196706&rft.externalDocID=PMC8438258 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0449-3060&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0449-3060&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0449-3060&client=summon |